Magdy Fouad, investors relations manager at Alexandria Company for Pharmaceuticals and Chemical Industries, revealed that the hike in the company profits in the five months ending in November 2017 can be traced back to a surge in the prices of drugs during the last period. “Revenues witnessed a hike as the company’s sales greatly increased,” …